Feasibility and kinetic characteristics of 68Ga-NOTA-RGD PET for in vivo atherosclerosis imaging

[1]  Sungeun Kim,et al.  High-sensitivity C-reactive protein in the low- and intermediate-Framingham risk score groups: analysis with 18F-fluorodeoxyglucose positron emission tomography. , 2013, International journal of cardiology.

[2]  D. Schuppan,et al.  Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis , 2009, Hepatology.

[3]  M. Reiser,et al.  18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease , 2009, Journal of Nuclear Medicine.

[4]  J. Knuuti,et al.  68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  H. Sillesen,et al.  Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  A. Walch,et al.  Evaluation of &agr;v&bgr;3 Integrin-Targeted Positron Emission Tomography Tracer 18F-Galacto-RGD for Imaging of Vascular Inflammation in Atherosclerotic Mice , 2009, Circulation. Cardiovascular imaging.

[7]  R. Virmani,et al.  Clinical Feasibility of Molecular Imaging of Plaque Inflammation in Atherosclerosis , 2009, Journal of Nuclear Medicine.

[8]  G. Hankey,et al.  Effect of Long-Term Homocysteine Reduction with B Vitamins on Arterial Wall Inflammation Assessed by Fluorodeoxyglucose Positron Emission Tomography: A Randomised Double-Blind, Placebo-Controlled Trial , 2009, Cerebrovascular Diseases.

[9]  W. Heindel,et al.  Fluorescence Reflectance Imaging of Macrophage-Rich Atherosclerotic Plaques Using an αvβ3 Integrin–Targeted Fluorochrome , 2008, Journal of Nuclear Medicine.

[10]  Young Joo Kim,et al.  Preparation of a Promising Angiogenesis PET Imaging Agent: 68Ga-Labeled c(RGDyK)–Isothiocyanatobenzyl-1,4,7-Triazacyclononane-1,4,7-Triacetic Acid and Feasibility Studies in Mice , 2008, Journal of Nuclear Medicine.

[11]  S. Nekolla,et al.  Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. , 2008, Cardiovascular research.

[12]  K. Berger,et al.  Noninvasive Detection and Localization of Vulnerable Plaque and Arterial Thrombosis With Computed Tomography Angiography/Positron Emission Tomography , 2008, Circulation.

[13]  S. Laurent,et al.  Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. , 2008, Cardiovascular research.

[14]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[15]  P. Libby,et al.  Molecular imaging of cardiovascular disease. , 2007, Circulation.

[16]  A. Arauz,et al.  Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography Pilot study , 2007, Clinical Neurology and Neurosurgery.

[17]  T. Imaizumi,et al.  Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. , 2007, Journal of the American College of Cardiology.

[18]  J. Jeng,et al.  Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[20]  Masatoshi Ishibashi,et al.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.

[21]  Takashi Kato,et al.  Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  David Zurakowski,et al.  Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Murabito,et al.  Prognosis After the Onset of Coronary Heart Disease An Investigation of Differences in Outcome Between the Sexes According to Initial Coronary Disease Presentation , 1993, Circulation.

[24]  A. Maseri,et al.  Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.

[25]  S. Gambhir,et al.  Quantitative PET Imaging of Tumor Integrin αvβ3 Expression with 18F-FRGD2 , 2006 .

[26]  A. Maseri,et al.  Coronary constriction in acute myocardial infarction: role of nitrates. , 1988, European heart journal.